The Src family kinases has critical roles in the process of cancer invasion (Kim et al, 2009), and preclinical data indicates that Src inhibition may add to tumour control in advanced malignancies including melanoma (Eustace et al, 2008; Homsi et al, 2009; Fraser et al, 2010). This evidence concerns the gene SRC and neoplasm.